J Y Hu1, G Z Jin. 1. Department of Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China.
Abstract
AIM: To study the role of dopamine (DA) receptors in l-tetrahydropalmatine (l-THP)-induced antinociception. METHODS: The intraperitoneal (i.p.) and intrathecal (ith) injections were used to give the drugs. The tail-flick test was used to assess the nociceptive threshold of rats. RESULTS: By i.p. injection, l-THP (10, 20, 40 mg.kg-1) as well as D2 receptor antagonist spiperone (1, 2, 3 mg.kg-1) produced dose-dependent antinociceptive effects on the nociception of rats, while D2 receptor agonist quinpirole, D1 receptor agonist SKF38393, and D1 receptor antagonist Sch-23390 showed no antinociception. Moreover, l-THP- or spiperone-induced antinociception was markedly attenuated by quinpirole (2, 3 mg.kg-1) but not SKF38393 or naloxone. On the other hand, ith quinpirole (20, 30, 40 micrograms.kg-1) also induced a dose-dependent antinociception, while ith l-THP, spiperone, SKF38393, and Sch-23390 did not exhibit any antinociception. Furthermore, ith spiperone (20, 30, 40 micrograms.kg-1) but not Sch-23390 dose-dependently antagonised the antinociception induced by quinpirole. l-THP (ith, 100, 200, 300 micrograms.kg-1) also dramatically attenuated the quinpirole-induced antinociception with a dose-dependent relationship. CONCLUSION: Activating the spinal D2 receptor or blocking the supraspinal D2 receptor produces antinociception. D1 receptor might be not directly involved in the antinociception. l-THP (as a D2 antagonist) as well as spiperone produces antinociception via blocking the supraspinal D2 receptor.
AIM: To study the role of dopamine (DA) receptors in l-tetrahydropalmatine (l-THP)-induced antinociception. METHODS: The intraperitoneal (i.p.) and intrathecal (ith) injections were used to give the drugs. The tail-flick test was used to assess the nociceptive threshold of rats. RESULTS: By i.p. injection, l-THP (10, 20, 40 mg.kg-1) as well as D2 receptor antagonist spiperone (1, 2, 3 mg.kg-1) produced dose-dependent antinociceptive effects on the nociception of rats, while D2 receptor agonist quinpirole, D1 receptor agonist SKF38393, and D1 receptor antagonist Sch-23390 showed no antinociception. Moreover, l-THP- or spiperone-induced antinociception was markedly attenuated by quinpirole (2, 3 mg.kg-1) but not SKF38393 or naloxone. On the other hand, ithquinpirole (20, 30, 40 micrograms.kg-1) also induced a dose-dependent antinociception, while ithl-THP, spiperone, SKF38393, and Sch-23390 did not exhibit any antinociception. Furthermore, ithspiperone (20, 30, 40 micrograms.kg-1) but not Sch-23390 dose-dependently antagonised the antinociception induced by quinpirole. l-THP (ith, 100, 200, 300 micrograms.kg-1) also dramatically attenuated the quinpirole-induced antinociception with a dose-dependent relationship. CONCLUSION: Activating the spinal D2 receptor or blocking the supraspinal D2 receptor produces antinociception. D1 receptor might be not directly involved in the antinociception. l-THP (as a D2 antagonist) as well as spiperone produces antinociception via blocking the supraspinal D2 receptor.
Authors: John R Mantsch; Samantha Wisniewski; Oliver Vranjkovic; Corey Peters; Amanda Becker; Abbey Valentine; Shi-Jiang Li; David A Baker; Zheng Yang Journal: Pharmacol Biochem Behav Date: 2010-09-09 Impact factor: 3.533
Authors: Yazmin Figueroa-Guzman; Christopher Mueller; Oliver Vranjkovic; Samantha Wisniewski; Zheng Yang; Shi-Jiang Li; Colin Bohr; Evan N Graf; David A Baker; John R Mantsch Journal: Drug Alcohol Depend Date: 2010-12-31 Impact factor: 4.492
Authors: Mingming Yu; Hazem E Hassan; Ahmed Ibrahim; Kenneth S Bauer; Deanna L Kelly; Jia Bei Wang Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2014-06-20 Impact factor: 3.205
Authors: Andrea Gail Nackley; Kai Soo Tan; Karamarie Fecho; Patrick Flood; Luda Diatchenko; William Maixner Journal: Pain Date: 2006-11-07 Impact factor: 7.926